The Short Answer
Hims & Hers stock (HIMS) is generally halal for Muslim investors, though with some product-specific nuance. The core business — providing telehealth consultations and prescription medication delivery for legitimate medical conditions — is permissible. Healthcare and medicine that preserve life and wellbeing (hifz al-nafs) are strongly encouraged in Islam.
Certain product categories (sexual wellness, some cosmetic treatments) may give individual Muslim investors pause based on their personal interpretation. However, on the whole, Hims & Hers passes Sharia screening with a halal verdict from major agencies.
Sharia Screening Methodology
Islamic scholars use several criteria to screen stocks:
- Business activity screen: Is the company's primary business halal?
- Debt ratio: Total debt / market cap must be under 33%
- Interest income: Interest income / total revenue must be under 5%
- Haram revenue: Revenue from haram sources must be under 5%
- Receivables ratio: Total receivables / total assets must be under 49–70% (varies by board)
Hims & Hers' Business Activity
Hims & Hers operates a direct-to-consumer telehealth platform offering consultations with licensed healthcare providers and prescription or OTC treatment delivery. Product categories:
- Hair care (Hims): Finasteride and minoxidil for male hair loss — FDA-approved treatments for a medical condition
- Sexual health (Hims): Sildenafil (generic Viagra) and tadalafil for erectile dysfunction — prescribed for a medical condition within marriage
- Mental health: Antidepressants, anxiety medication, and therapy via telehealth
- Weight management: GLP-1 medications (semaglutide/compounded) for obesity — a significant and growing category
- Women's health (Hers): Birth control, menopause treatment, hair and skin care for women
- Primary care: Online urgent care, lab testing, and chronic disease management
The majority of Hims & Hers revenue comes from treating legitimate medical conditions. Islam strongly supports medicine and healthcare — the Prophet Muhammad (peace be upon him) said: "Make use of medical treatment, for God has not made a disease without appointing a remedy for it." (Abu Dawud)
Financial Ratios (2025)
Based on Hims & Hers' most recent financial statements:
- Total Debt / Market Cap: ~10% ✅ (threshold: under 33%)
- Interest Income / Revenue: ~1% ✅ (threshold: under 5%)
- Haram Revenue: Minimal, if any ✅
- Receivables Ratio: Within limits ✅
Hims & Hers passes all four key Sharia financial screens.
Concerns to Be Aware Of
1. Sexual Health Products
Hims sells erectile dysfunction medications, which are prescribed treatments for a medical condition affecting married couples. Islam does not prohibit medical treatment for sexual dysfunction within marriage — in fact, maintaining marital wellbeing is an Islamic obligation. Most scholars would not flag this as haram.
However, some Muslim investors may be personally uncomfortable with this product category regardless of the scholarly ruling.
2. Birth Control (Hers Platform)
The Hers platform offers contraception. Islamic scholars have nuanced views on birth control — some forms are permissible for legitimate reasons within marriage, others are controversial. Birth control represents a small portion of overall revenue.
3. Compounded GLP-1 Controversy
Hims has been a significant seller of compounded semaglutide (a generic version of Ozempic/Wegovy) during the shortage period. There are regulatory questions about the ongoing availability of this product as FDA-authorized supplies normalize. This is a business risk, not a Sharia concern.
4. Mental Health Medications
Hims & Hers prescribes antidepressants and anxiety medications — treatments for recognized medical conditions. These are permissible treatments under Islamic principles of preserving health.
Verdict from Major Screening Agencies
Hims & Hers stock is screened as compliant (halal) by:
- Zoya App — Compliant ✅
- MSCI Islamic criteria — Generally meets criteria ✅
- Most major Sharia advisory boards — Approved ✅
Bottom Line
Hims & Hers (HIMS) is generally halal for Muslim investors. Its telehealth platform primarily treats legitimate medical conditions, the company passes all Sharia financial screens, and there are no significant haram revenue sources. Individual Muslim investors may have personal comfort considerations around specific product categories, but the mainstream Sharia verdict is halal.
HIMS represents an interesting way to invest in the direct-to-consumer healthcare and telehealth sector from a Sharia-compliant perspective, with significant growth potential from the weight management category.
Want to check if another stock is halal? Use our free screener.
Open Halal Checker →